| Literature DB >> 31826803 |
Danillo Menezes Dos Santos1, Jullyana S S Quintans1, Lucindo J Quintans-Junior1, Valter J Santana-Filho2, Cláudio Leinig Pereira da Cunha3, Igor Alexandre Cortes Menezes4, Márcio R Viana Santos1.
Abstract
Although increasing evidence supports the monitoring of peripheral perfusion in septic patients, no systematic review has been undertaken to explore the strength of association between poor perfusion assessed in microcirculation of peripheral tissues and mortality. A search of the most important databases was carried out to find articles published until February 2018 that met the criteria of this study using different keywords: sepsis, mortality, prognosis, microcirculation and peripheral perfusion. The inclusion criteria were studies that assessed association between peripheral perfusion/microcirculation and mortality in sepsis. The exclusion criteria adopted were: review articles, animal/pre-clinical studies, meta-analyzes, abstracts, annals of congress, editorials, letters, case-reports, duplicate and articles that did not present abstracts and/or had no text. In the 26 articles were chosen in which 2465 patients with sepsis were evaluated using at least one recognized method for monitoring peripheral perfusion. The review demonstrated a heterogeneous critically ill group with a mortality-rate between 3% and 71% (median=37% [28%-43%]). The most commonly used methods for measurement were Near-Infrared Spectroscopy (NIRS) (7 articles) and Sidestream Dark-Field (SDF) imaging (5 articles). The vascular bed most studied was the sublingual/buccal microcirculation (8 articles), followed by fingertip (4 articles). The majority of the studies (23 articles) demonstrated a clear relationship between poor peripheral perfusion and mortality. In conclusion, the diagnosis of hypoperfusion/microcirculatory abnormalities in peripheral non-vital organs was associated with increased mortality. However, additional studies must be undertaken to verify if this association can be considered a marker of the gravity or a trigger factor for organ failure in sepsis.Entities:
Keywords: Microcirculation; Microcirculação; Mortalidade; Mortality; Perfusion; Perfusão; Review; Revisão; Sepse; Sepsis
Mesh:
Year: 2019 PMID: 31826803 PMCID: PMC9391865 DOI: 10.1016/j.bjan.2019.09.007
Source DB: PubMed Journal: Braz J Anesthesiol ISSN: 0104-0014
Figure 1Flowchart of included articles. The articles that was not related to primary studies of prognosis were excluded according to the following exclusion criteria: duplicated studies, articles did not present abstracts and/or no text, articles not shown in full (abstracts, conference reports, conference posters, editorials, letters, case reports), reviews or meta-analyses, animal or pre-clinical studies, and whose subject did not meet the criteria of this study.
Main methods used to directly or indirectly monitor peripheral perfusion in sepsis studies with mortality predictions.
| Methods | How to interpret the measurement/estimation of peripheral perfusion |
|---|---|
| Orthogonal Polarization Spectral imaging (OPS) and Sidestream Dark Field imaging (SDF) | Techniques that use reflected light to produce real-time images of microcirculation. Using a hand-held video-microscope, OPS and SDF can assess microvascular density and perfusion. A semi-quantitative score (Microcirculatory Flow Index ‒ MFI) is usually used to characterize microcirculatory flow. Microcirculatory density can be assessed as the Total Vessel Density (TVD) and Perfused Vessel Density (PVD). The PVD/TVD ratio is used to express the Proportion of Perfused Vessels (PPV). Quantitative assessment of microcirculation can also be performed. |
| Near Infrared Spectroscopy (NIRS) | A technique that uses the principles of light transmission/absorption to measure tissue oxygen saturation (StO2) and other parameters such as concentration of myoglobin and oxidized cytochrome. It provides a global assessment of oxygenation in all microvascular compartments (arterial, venous, and capillary). StO2 is partly related to blood flow and has been shown to be a parameter for determining the balance between oxygen supply and oxygen demand. Blood flow can also be estimated using venous occlusion and hemoglobin concentration. Conversely, arterial occlusion can be used to study microvascular reactivity. |
| Transcutaneous oxygen measurement and the Oxygen Challenge Test (OCT) | Subcutaneous partial oxygen pressure (PtcO2) can be measured using non-invasive transcutaneous probes. The Oxygen Challenge Test (OCT) consists of the PtcO2 response to increasing the fraction of inspired oxygen (Fio2) to 100% for a 5–15 minutes period. It is related to global oxygen delivery and tissue perfusion. Therefore, the PtcO2 increases with increasing FiO2 in normal perfusion states, whereas PtcO2 poorly responds to increasing FiO2 in hypoperfusion states. |
| Temperature values and gradients | Skin temperature is a traditional sign of peripheral vasoconstriction and reduced blood flow; cold skin temperature is related to a lower cardiac index and higher arterial lactate. Temperature gradients can better reflect cutaneous blood flow than skin temperature itself. |
| Skin mottling | Defined as “patchy skin discoloration”, it usually manifests around the knees and might extend to other sites such as the fingers and ears. It is a result of the heterogeneous vasoconstriction of small vessels and is an easily assessed sign of peripheral hypoperfusion. Skin mottling scores range from 0 to 5 based on the extension from the knees to the peripheral areas. |
| Oximetry-derived Perfusion Index (PI) | Represents the ratio between the pulsatile and nonpulsatile component of photoplethysmography signal from oximetry. |
| As blood flow changes affect only the pulsatile (arterial) component of the signal, PI is considered a numerical non-invasive measure of peripheral perfusion. | |
| Capillary Refill Time (CRT) | Defined as “the time needed for skin color to return to baseline on a fingertip after application of blanching pressure”, thus estimating the peripheral capillary blood flow |
| Laser Doppler Flowmetry combined with Visible Light Spectroscopy (LDF/VLS) | LDF provides continuous measurement of microcirculatory blood flow in arbitrary perfusion units using the principle of doppler shift: the frequency change that light undergoes when reflected by moving objects, e.g. red blood cells. |
| VLS is performed by emitting light in the visible range (white light) and detecting the back scattered light. The main absorber, haemoglobin, changes its absorption characteristics with oxygenation (HbO2). | |
| Retinal fluorescein angiography | Fluorescein is given intravenously and retina images are obtained using a digital camera. |
| The Retinal Arterial Filling Time (RAFT) is used to measure microvascular flow. | |
Characteristic and methodological qualities of included studies and characteristics of septic patients.
| Reference (Country) | Study design | Source of Sepsis | Age Mean ± SD or Median (IQR) | APACHE II Mean ± SD or Median (IQR) | SOFA Mean ± SD or Median (IQR) | MAP Mean ± SD/SE or Median (IQR) | Heart Rate Mean ± SD or Median (IQR) | Arterial Lactate Mean ± SD or Median (IQR) | NOS Score |
|---|---|---|---|---|---|---|---|---|---|
| De Backer et al., | Single-center prospective study | Abdominal, | Healthy volunteers: | N/A | N/A | 82 (80-87) | 69 (64-72) | N/A | 6 |
| Sakr et al., | Single-center prospective study | Abdominal, Genitourinary, Respiratory, | All Patients: 66 (51–78) | 16 (13-19) | 10 (9-12) | 70 (63-79) | 104 (96-118) | 2.1 (1.2–3.4) | 7 |
| Doerschug et al., | Single-center prospective study | Data not | Severe sepsis patients | Data not shown | 9 | 69 | 92 | 3.0 | 6 |
| Trzeciak et al., | Single-center prospective study | Abdominal, Genitourinary, Respiratory, | All septic patients 61 ± 15 | Data not shown | 5.8 ± 3.8 | 71 ± 10 | Data not shown | N/A | 6 |
| Leone et al., | Single-center | Respiratory | Survivors 59 (40–67) | Data not shown | Data not shown | 79 (72–87) | 100 (85–114) | 2.3 (1.4–2.9) | 7 |
| Spanos et al., | Single-center prospective study | Abdominal, Genitourinary, Respiratory, | Sepsis 33 (25–58) | 8 ± 5 | Data not shown | 88 ± 15 | 115 ± 15 | N/A | 6 |
| Sakr et al., | Single-center prospective study | Respiratory, | All patients 61 ± 11 | 28.8 ± 6.4 | 10.6 ± 3.4 | Data not shown | Data not shown | Data not shown | 5 |
| Ait-Oufella et al., | Single-center prospective study | Respiratory, | All patients 66 ± 16 | Data not shown | 11.5 (8.5 – 14.5) | Data not shown | Data not shown | Data not shown | 5 |
| Rodriguez et al., | Single-center prospective study | Abdominal, Genitourinary Respiratory | All Patients 65.0 ± 12.3 | 24.4 ± 7.5 | 9.0 ± 2.6 | 73.6 ± 7.3 | Data not shown | N/A | 6 |
| Shapiro et al., | Multicenter prospective study | Data not shown | Septic shock 68 ± 16 | Data not shown | Data not shown | 75 ± 19 | Data not shown | 3.5 ± 2.5 | 7 |
| Ait-Oufella et al., | Single-center prospective study | Respiratory, | All patients 68 ± 15 | Data not shown | 11 (9-15) | 75 ± 14 | Data not shown | 5.4 ± 4.8 | 5 |
| Edul et al., | Single-center prospective study | Abdominal | Survivor 69 ± 13 | 22 ± 5 | 9 ± 3 | 78 ± 13 | 88 ± 12 | 1.9 ± 1.1 | 6 |
| De Backer et al., | Single-center | Abdominal, Genitourinary Respiratory, | All patients 69 (55–76) | N/A | N/A | N/A | N/A | 2.1 (1.3–3.3) | 7 |
| He et al., | Single-center | Abdominal, Bloodstream Genitourinary Respiratory, | Survivors 58 ± 16 | 18 ± 6 | 9 ± 2 | Data not | Data not | 2.3 ± 2.0 | 4 |
| Hernandez et al., | Multicenter | Abdominal, | All patients 65 (18-84) | 21 (18-25) | 10 (7-12) | 67 (61-72) | Data not shown | 2.3 (1.3-4.5) | 5 |
| Ait-Oufella et al., | Single-center prospective study | Abdominal,Genitourinary | All patients 69 ± 14 | Data not shown | 10 (7-14) | 76 ± 10 | Data not shown | 4.5 ± 4.6 | 8 |
| Mari et al., | Single-center | Respiratory | Survivors 54 ± 19 | Data not shown | 9 ± 4 (T0) | 80 ± 11 (T0) | 100 ± 23 (T0) | 2.9 ± 2.4 (T0) | 5 |
| Galbois et al., | Single-center | Abdominal, Genitourinary Respiratory, | All patients 58.7 (52.4-68.5) | 14 (12-18) | Data not shown | Data not shown | Data not shown | Data not shown | 6 |
| Rasmy et al., | Single-center | Abdominal | All patients 50 ± 17.9 | 21 ± 11 | 4 ± 2 | N/A | N/A | N/A | 8 |
| Rodríguez et al., | Single-center | Respiratory | All Patients 55.0 ± 16.3 | 15.6 ± 6.3 | 4.2 ± 1.9 | Data not shown | Data not shown | Data not shown | 5 |
| Bourcier et al., | Single-center | Respiratory | Severe sepsis 65 (56-73) | Data not shown | 4 (3-5) | 75 (69-84) | Data not shown | 1.2 (0.9-1.9) | 8 |
| Houwink et al., | Single-center | Data not shown | All patients 64.0 ± 14.4 | 0.34 (0.16–0.60) | 7.8 ± 3.7 | 76.9 ± 21 | Data not shown | 1.9 (1.2–3.5) | 4 |
| Erikson et al., | Single-center | Respiratory | All patients 62.1 (50.6–75.8) | 22 (18–25) | 8 (5–10) | 73.9 (68–88) | Data not shown | 1.9 (1.3–2.5) | 8 |
| Fontana et al., | Single-center | Respiratory | All patients 64 ± 16; | 22 (17-28) | 10 (8-12) | 70 (67–77) | 104 (92–120) | 2.0 (1.3–3.2) | 9 |
| Lara et al., | Single-center | Abdominal | All patients 67 ± 18 | 16 (10-21) | 4 (2-7) | 84 ± 20 | 110 ± 21 | 4.3 ± 2.5 | 8 |
| Macdonald et al., | Multicenter, prospective study | Respiratory | Control 61 (44–75) | Data not shown | 1 (0–1) | Data no shown | 108 ± 18 | 1.8 ± 0.8 | 6 |
APACHE, acute physiology and chronic health evaluation; SOFA, sequential organ failure assessment; MAP, mean arterial pressure; DAA, drotrecogin alfa activated; SD, standard desviation; SE, standard error; N/A, not available; CNS, central nervous system; NOS, Newcastle-Ottawa scale for quality assessment of studies.
Association between diagnosis of peripheral hypoperfusion and mortality in sepsis.
| Reference | Methodology | Main results | |
|---|---|---|---|
| Mortality | Peripheral perfusion | ||
| De Backer et al. | Adults from an ICU; Groups: Control (n = 10), patients with sepsis (n = 50), patients before cardiac surgery (n = 16) and acutely ill non-infected patients (n = 5). Sublingual microcirculation was investigated with OPS imaging. | 44% (follow-up time was not clearly stated) | Proportion of perfused small vessels was reduced in septic patients when compared to the control group. The most severe impairments in microvascular blood flow were found in non-survivor septic patients. |
| Sakr et al. | Adults from an ICU; Groups: control group (4) and septic shock (n = 46). Sublingual microcirculation was investigated with OPS imaging. | 43% at 7 days | At the onset of shock, survivors and non-survivors had similar vascular densities and percentages of perfused small vessels. Small vessel perfusion improved over time in survivors but not in non-survivors. Microcirculatory alterations were similar in those who died multiple organ failure (MOF) after resolution of the shock and those who died of shock. |
| Doerschug et al. | Adults from an ICU; Groups: Control (n = 15) and severe sepsis (n = 24). Microvascular flow was estimated by the NIRS method. | 33% at 30 days | This study showed that microvascular hemoglobin was significantly reduced in septic patients. Also, the rate of tissue oxygen consumption and the rate of increase in StO2 during reactive hyperemia were significantly slower in septic patients. Resting StO2 measured 24 h after the onset of organ dysfunction was not associated with organ failure or survival at 7, 14, or 30 days. |
| Trzeciak et al. | Adults from an ED and ICU; Groups: Control (n = 5) and severe sepsis/septic shock (n = 26). The sublingual microcirculation was assessed by OPS imaging. | 42% (In-hospital mortality) | Early microcirculatory indices (lower flow velocity and heterogeneous perfusion) were more markedly impaired in non-survivors compared to survivors. These same indices were more markedly impaired with increasing severity of systemic cardiovascular dysfunction. |
| Leone et al. | Adults from an ICU; Groups: No control group and septic shock (n = 42). Tissue oxygen saturation (StO2) was monitored using the NIRS method. | 31% at 28 days | The StO2 values were significantly lower in the non-survivors than in the survivors. In septic shock patients, tissue oxygen saturation below 78% was associated with increased 28-day mortality. |
| Spanos et al. | Adults from an ED; Groups: Control (n = 16), sepsis (n = 29) and severe sepsis (n = 19). The sublingual microcirculation was evaluated using SDF imaging. | 3% sepsis | Microvascular flow index and perfused vessel density were small in the severe sepsis group compared to the sepsis group. The proportion of perfused vessels was significantly reduced in those patients who did not survive. |
| Sakr et al. | Adults from ICU; Groups: healthy volunteers (n = 20), ICU control group (n = 8) and septic shock (n = 21). The perfusion was measured with LDF/VLS. | 47% in-ICU mortality | Buccal mucosal HbO2 within 24 h of onset of septic shock was lower in non-survivors than in survivors. Buccal mucosal flow increased during the 2nd day of septic shock in survivors and decreased thereafter. |
| Ait-Oufella et al. | Adults from an ICU; Groups: No control, septic shock (n = 60). The microvascular perfusion was studied using the skin motlling score. | 45% at 14 days | The mottling score was a strong predictor of mortality, reaching an odds ratio of 74 when the score was 4-5. |
| Rodriguez et al. | Adults from an ICU; Groups: Control (n = 50) and septic shock (n = 19). The regional oxygen saturation index (rSO2) was obtained in the brachioradialis muscle. Measurements were performed using the NIRS method. | 57 % (follow-up time was not clearly stated) | In septic shock, rSO2 values were lower in non-survivors than in survivors at baseline, 12 hours and 24 hours after ICU admission. |
| Shapiro et al. | Adults from an ED; Groups: control group (n = 50), septic shock (n = 58) and sepsis (n = 60). The perfusion was assessed by tissue StO2 using the NIRS method. | Sepsis 5% septic shock 38% in-hospital mortality | NIRS measurements for the initial StO2, StO2 occlusion slope and StO2 recovery slope were lower in patients with septic shock compared to septic patients. The recovery slope was most strongly associated with organ dysfunction and mortality. However, StO2 was not different between survivors and non-survivors, with a poor area under the curve for mortality (0.56). |
| Ait-Oufella et al. | Adults from an ICU; Groups: No control group and septic shock (n = 52). The perfusion was assessed by tissue StO2 measured using the NIRS method around the knee. | 48% at 14 days | After initial septic shock resuscitation, lower StO2 measured around the knee is a strong predictive factor of 14-day mortality. |
| Edul et al. | Adults from an ICU; Groups: control group (n = 25) and septic shock (n = 25). Sublingual microcirculation was evaluated using SDF imaging. | 56% in-hospital mortality | Using a quantitative assessment of SDF, the non-survivors exhibited decreased perfused capillary density, proportion of perfused capillaries, and microvascular flow index along with increased heterogeneity flow index compared with the survivors. |
| De Backer et al. | Adults from an ICU; Groups: No control group and severe sepsis (n = 252). Sublingual microcirculation was evaluated with SDF or OPS imaging. | 51% in-ICU mortality | Survival rates decreased markedly with severity of alterations in the proportion of perfused small vessels (the lower quartiles). Mortality was significantly higher in patients with lower microvascular perfusion measured by these methods. |
| He et al. | Adults from an ICU; Groups: Control (n = 20) and septic shock (n = 46). Oximetry-derived PI and 10 min-OCT were used to estimate perfusion. | 43% in-ICU mortality | The PI and OCT were predictive of mortality for septic patients after resuscitation. The sensitivity and specificity for mortality were 65% and 92%, respectively, for the PI. The sensitivity and specificity were 65% and 96%, respectively, for the OCT. |
| Hernandez et al. | Adults; Groups: No control group and septic shock (n = 122). Sublingual microcirculation was evaluated using SDF imaging. | 33% in-hospital mortality | Perfused vessel density was significantly related to organ dysfunctions and mortality in septic shock patients, particularly in patients exhibiting more severe abnormalities (lowest quartile of distribution for this parameter). |
| Ait-Oufella et al. | Adults from an ICU; Groups: No control and septic shock (n = 59). The perfusion was evaluated using CRT on the finger and on the knee area. | 36% at 14 days | The CRT was strongly predictive of mortality. The area under the curve for prediction was 84% (75–94) for the finger measurement and 90% (83–98) for the knee area. |
| Mari et al. | Adults from an ICU; Groups: no control group and septic shock (n = 56). Peripheral perfusion assessment was measured using 15 minutes-OCT. | 31% at 28 days | At admission (T0), 15 min-OCT was similar between survivors and non-survivors. 24 h after admission (T24), survivors had a significantly higher OCT value than non-survivors. |
| Galbois et al. | Adults from an ICU; Groups: Control (n = 75) and patients with liver cirrhosis admitted for septic shock (n = 42). Skin perfusion was assessed by the skin mottling score and tissue StO2 measured using the NIRS method. | 71% at 14 days | Mottling score and knee StO2 at 6 h after admission were very specific predictors of 14-day mortality in patients with cirrhosis and septic shock. |
| Rasmy et al. | Adults from an ICU; Groups: No control group and severe sepsis (n = 36), divided in treated with vasopressors (n = 21) and without vasopressors (n = 15). Oximetry-derived PI was used to measure peripheral perfusion. | 40% at 28 days | PI was able to predict mortality with varying sensitivity and specificity. The best cut-off of PI was 0.21 (sensitivity 86% and specificity 90%). |
| Rodríguez et al. | Adults from an ICU; Groups: No control group and sepsis (n = 19). Two probes of an NIRS device were simultaneously placed on the brachioradialis and deltoid muscles. | 21% in-ICU mortality | Non-survivors had rSO2 values significantly lower than survivors at all times of the study. Both muscles showed consistent discriminatory power for mortality. |
| Bourcier et al. | Adults from an ICU; Groups: no control group, severe sepsis (n = 40) and septic shock (n = 63). Peripheral perfusion was measured with four temperature gradients, CRT and mottling score. | 36% in-ICU mortality | Toe-to-room temperature gradient and its variations are independent predictors of mortality due to multi-organ failure in patients with septic shock. Increased CRT and high mottling score were also predictors of mortality |
| Houwink et al. | Adults from an ICU; Groups: no control group, septic shock (n = 821). Peripheral perfusion was measured with temperature gradient central-peripheral (Delta T). | 26% in-hospital mortality | Delta T at 24 hours, but not at admission, is independently associated with mortality. |
| Erikson et al. | Adults from an ICU; Groups: no control group and sepsis (n = 31). Retinal blood flow was measured using fluorescein angiography and RAFT. | 12% at 30 days | There were no differences in mortality rates between the patients with different retinal blood flow (lower or higher RAFT). |
| Fontana et al. | Adults from an ICU; Groups: No control group, severe sepsis (n = 27) and septic shock (n = 95). Microcirculation was evaluated using SDF imaging. | 43% in-ICU mortality | PPV and MFI were lower in non-survivors than in survivors. These parameters were independent predictors of mortality |
| Lara et al. | Adults from an ED; Groups: no control group and sepsis (n = 95). Peripheral perfusion assessment was measured by CRT. | 63% in-hospital mortality | Hyperlactatemic septic patients with abnormal CRT after initial fluid resuscitation exhibited higher mortality and worse clinical outcomes than patients with normal CRT |
| Macdonald et al. | Adults from an ED; Groups: control group (n = 180) and sepsis (n = 143). Perfusion was assessed by StO2 using the NIRS method. | 7% at 28 days | StO2 less than 75% at 72 hours after admission was associated with in-hospital mortality/ICU admission, independent of both qSOFA and lactate. |
CRT, capillary refill time; ED, emergency department; HbO2, oxygen haemoglobin saturations; ICU, intensive care unit; LDF, laser doppler flowmetry; MFI, microvascular flow index; NIRS, near infrared spectroscopy; OCT, transcutaneous oxygen challenge; OPS, orthogonal polarization spectral; PI, perfusion index; PPV, proportion of perfused small vessels; RAFT, retinal arterial filling time; rSO2, regional oxygen saturation index; SOFA, sequential organ failure assessment; StO2, tissue oxygen saturation; VLS, visible light spectroscopy.
Timing of evaluation of microcirculation or peripheral perfusion.
| Reference | Timing of patient evaluation |
|---|---|
| De Backer et al. | Was not clearly informed |
| Sakr et al. | At inclusion and at 24 hours intervals after initial fluid resuscitation, during the circulatory shock |
| Doerschug et al. | After fluid resuscitation, 24 hours after diagnosis |
| Trzeciak et al. | During the first 6 hours of fluid resuscitation |
| Leone et al. | After the macrohemodynamic variables seemed optimal to attending physician (after fluid resuscitation) |
| Spanos et al. | During the first 6 hours of fluid resuscitation |
| Sakr et al. | Within first 24 hours of management and at 24 hours intervals, during the circulatory shock |
| Ait-Oufella et al. | After initial 6 hours of fluid resuscitation |
| Rodriguez et al. | At ICU admission, 12 and 24 hours after beggining of fluid resuscitation (admission) |
| Shapiro et al. | Was not clearly informed |
| Ait-Oufella et al. | After initial 6 hours of fluid resuscitation |
| Edul et al. | During the first 24 hours after admission after initial management and hemodynamic stabilization |
| De Backer et al. | Within 24 hours of the onset of sepsis and after 48 hours of the onset of sepsis |
| He et al. | After fluid resuscitation, after initial 24 hours of management |
| Hernandez et al. | Within 24 hours of septic diagnosis and fluid resuscitation |
| Ait-Oufella et al. | After initial 6 hours of fluid resuscitation |
| Mari et al. | After initial 6 hours of fluid resuscitation and hemodynamic stabilization |
| Galbois et al. | During and after initial fluid resuscitation (6 hours intervals during the initial 24 hours of management in ICU) |
| Rasmy et al. | After initial 6 hours of fluid resuscitation |
| Rodríguez et al. | At ICU admission and 24 hours after beggining of fluid resuscitation (admission) |
| Bourcier et al. | After initial 6 hours of fluid resuscitation |
| Houwink et al. | During the first 24 hours after admission |
| Erikson et al. | During the first 24 hours after admission, 2–5 days later and 3–6 months after the hospital discharge. |
| Fontana et al. | Median of 2 days after admission ‒ Interquartile range (1‒3 days) |
| Lara et al. | Before and after initial 6 hours of fluid resuscitation |
| Macdonald et al. | At inclusion and after 3 hours of management |